Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company